Oxygen supplementation at higher levels for critically ill patients: Uncertain effects but may increase mortality and adverse effects
Citation: Barbateskovic M, Schjørring OL, Russo Krauss S, et al. Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit. Cochrane Database of Systematic Reviews 2019; (11): CD012631.
What is this? Some patients with COVID-19 will become critically ill and need help with their breathing. They may be given extra oxygen to breathe, which might be provided by mechanical ventilation (MV) in an intensive care unit (ICU). Clinicians need to decide on the amount of supplemental oxygen to use.
In this Cochrane systematic review, the authors searched for randomized trials of the effects of different levels of supplemental oxygen in adult ICU patients. They did not restrict by date, type or language of publication and did their searches in December 2018. They identified 10 studies (1458 participants). All the studies compared more with less oxygen, but using very different levels of oxygen supplementation.
What works: Nothing noted.
What doesn’t work: Nothing noted.
What’s uncertain: The effects of higher levels of oxygen are uncertain, but higher levels may increase mortality and adverse effects.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.